HepLink Launches Using MediRecords to Expand Hepatitis C Care
March 30, 2026
Media Release
Hepatitis Australia has launched a new national telehealth service designed to deliver unprecedented access to hepatitis C testing and treatment, helping Australia move closer to eliminating hepatitis C as a public health threat.
The service forms part of HepLink, the national hepatitis information and linkage service, and allows people anywhere in Australia to connect with trained nurses, streamlined care pathways, and rapid access to treatment via telephone and virtual care.
Powered by MediRecords’ secure cloud technology and the Coviu telehealth platform, HepLink enables Australians to receive testing guidance, arrange blood tests, access clinical consultations and, where appropriate, receive prescriptions for curative hepatitis C treatment, without needing to attend an in-person appointment.
Hepatitis Australia CEO Lucy Clynes said the new service builds on the extraordinary progress Australia has made since hepatitis C cures were made widely available through the Pharmaceutical Benefits Scheme in 2016.
“More than 100,000 Australians have now accessed treatment and almost 100,000 have been cured of hepatitis C. That is one of the most significant public health achievements in a generation.
But around 63,000 Australians are still living with hepatitis C and many are unaware they have it or are not currently connected to care. HepLink helps close that gap by making testing, treatment and expert support easier to access from anywhere in the country.”
Lucy Clynes, Hepatitis Australia CEO
Digitally enabled care pathway
The HepLink telehealth service is supported by secure cloud-based clinical technology from MediRecords and its Engage patient portal, integrated with the Coviu telehealth platform and AI Scribe technology, enabling an end-to-end digital care pathway for patients.
Through the system, nurses and clinicians can securely manage patient records, share information and education materials, arrange testing, conduct telehealth consultations and issue ePrescriptions where appropriate.
This digitally enabled workflow allows people to move from their first enquiry to treatment initiation through a streamlined virtual care model — removing barriers for those who may struggle to access traditional health services.
Alongside Canada, Australia is now among the only countries to offer a nationwide telehealth service of this kind.
HepLink also supports general practitioners who may be unfamiliar with hepatitis C treatment, offering guidance and referral pathways to ensure patients are not left untreated.
MediRecords CEO Matthew Galetto said digital health platforms play a critical role in expanding access to care for people who may otherwise fall through the cracks.
“Digital care models are essential to reaching patients who may not present through traditional healthcare pathways,” Mr Galetto said.
“By supporting HepLink with secure cloud infrastructure and integrated telehealth capability, we’re helping enable a scalable national approach to hepatitis C care.”
Matthew Galetto, MediRecords Founder and CEO
Supporting Australia’s elimination goal
Australia has made major progress toward eliminating hepatitis C since the introduction of direct-acting antiviral treatments in 2016.
Since then:
- The number of Australians living with chronic hepatitis C has fallen by more than 60 per cent
- Deaths among people living with hepatitis C have declined significantly
- Almost half of treatments are now prescribed in primary care settings, improving access across the country.
However, treatment rates have slowed in recent years as remaining patients are harder to reach.
HepLink is designed to reconnect those individuals with care by providing confidential, easy-to-access support and clinical guidance.
Ms Clynes said initiatives like HepLink will be essential if Australia is to achieve its goal of eliminating hepatitis C.
“We now have the tools to cure hepatitis C quickly and safely,” she said.
“The challenge is ensuring people know about the cure and can access care when they need it. HepLink helps ensure no one misses the opportunity to be tested and treated.”
How to access HepLink
Anyone in Australia can access the HepLink service by calling 1800 437 222 or visiting www.heplink.au.
The service provides:
Information about hepatitis C testing
Support to arrange blood tests
Virtual clinical consultations where required
Access to prescriptions for curative treatment
HepLink is the national hepatitis information and linkage service operated by Hepatitis Australia in partnership with community hepatitis organisations nationally. HepLink is funded by the Australian Government Centre for Disease Control.
The HepLink telehealth service is made possible through a community grant from Gilead Sciences Australia.
MediRecords and Coviu are proud to support this vital healthcare initiative.
Media Enquiries
Hepatitis Australia: Darren Rodrigo, 0414 783 405
MediRecords: Matthew Galetto, CEO, [email protected], 0407 374 910
Coviu: Diana Pitts, CEO, [email protected], 02 7908 1346






